Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
IMscin001 Part 2: a randomised phase III, open-label, multicentre study examining the pharmacokinetics, efficacy, immunogenicity, and safety of atezolizumab subcutaneous versus intravenous administration in previously treated locally advanced or metastatic non-small-cell lung cancer and pharmacokinetics comparison with other approved indications
Mauricio Burotto, Zanete Zvirbule, A. Mochalova, Yotsawaj Runglodvatana, Luis A. Herráez-Baranda, Stephanie N. Liu and 7 more
- Rank
- 66 of 3,639
- Percentile
- top 1.9%
- Where
- Annals of Oncology, 2023
- Citations
- 56
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.